Trial Profile
Phase II clinical study on combination of oxaliplatin (L-OHP) and S-1 in advanced / recurrent gastric cancer untreated with chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Yakult Honsha
- 30 May 2016 New trial record